Genesys International Approves 2026 ESOP Scheme and Key Auditor Changes
Genesys International Corporation Ltd · Others (Uncategorized) · 03 Sept 2026, 1:13 am
Genesys International Approves 2026 ESOP Scheme and Key Auditor Changes Genesys International's board approved the "Genesys ESOP Scheme 2026", proposing up to 30,00,000 stock options. Additionally, the board granted 1,82,640 additional options under the 2022 ESOP scheme at an exercise price of ₹50 to adjust for a recent rights issue. On the governance front, G.K. Choksi & Co. will replace MSKA & Associates as Statutory Auditor for a 5-year term, while XAG & Co. was appointed Internal Auditor for FY26-27 following H.C. Vora & Associates' resignation. The 44th AGM is scheduled for 30th Sep'26.
Original exchange filing (PDF)
More announcements from Genesys International Corporation Ltd
- Genesys International Corporation Limited has informed the exchange regarding monitoring agency report for the quarter ended September 30, 2026 · 14 Nov 2026
- Genesys International Corporation Limited has informed the Exchange regarding Grant of Stock options 3,65,000 under Genesys Employee Option Scheme, 2022 ( Scheme) · 14 Nov 2026
- Outcome of Board Meeting held on November 13, 2026 regarding approval of Unaudited Standalone & Consolidated Financial Result for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- Press release issued by Genesys International Corporation Limited regarding Unaudited Standalone & Consolidated Financial Results for the quarter ended September 30, 2026 · 14 Nov 2026
- Genesys International Corporation Limited has informed the exchange regarding Unaudited Standalone and Consolidated Financial Result for the quarter and half year ended September 30, 2026 · 14 Nov 2026
- Genesys International Corporation Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 14 Nov 2026
- Genesys International Corporation Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
- Genesys International Corporation Limited has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. · 13 Nov 2026
